| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $28.4B | $33.7B | $35.1B | $28.8B | $23.5B | $18.7B | $25.6B | $23.5B |
| Cost of Revenue | $22.7B | $26.1B | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.4B | $0.5B | — | — | — | — | — | — |
| SG&A Expense | $0.7B | $0.7B | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $2.4B | $4.2B | $4.6B | $3.0B | $1.9B | $0.4B | $0.5B | $0.6B |
| EPS (Basic) | $4.52 | $7.92 | $8.78 | $5.76 | $5.33 | $1.17 | $1.53 | $1.66 |
| EPS (Diluted) | $4.51 | $7.90 | $8.76 | $5.75 | $5.32 | $1.17 | $1.53 | $1.65 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $44.3B | $43.4B | $40.8B | $33.3B | $29.3B | $28.3B | $28.4B | $25.5B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | $3.4B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $19.3B | $17.5B | $15.9B | $13.2B | $11.4B | $10.4B | $9.7B | $8.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.4B | $4.6B | $4.2B | $3.0B | $2.2B | $3.0B | $2.9B | $3.0B |
| Investing Cash Flow | $-2.3B | $-4.5B | $-2.9B | $-2.0B | $-1.4B | $-1.9B | $-2.2B | $-1.9B |
| Capital Expenditures | $0.7B | $0.8B | $0.7B | $0.5B | $0.6B | $0.6B | $0.6B | $0.5B |
| Financing Cash Flow | $-3.1B | $-0.1B | $1.1B | $0.3B | $-0.9B | $-1.8B | $0.1B | $0.1B |